Elanco Animal Health EV/EBIT ELAN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2019.

Today, Oct 23, 2026: n/m; not in our data today
Last meaningful: 388×; Feb 2025
7-year median: 49.7×
7-year range: 10.2× to 451×
Peer median: 54.6×

Elanco Animal Health has no meaningful EV/EBIT today: it is not in our data for Oct 23, 2026.

It was last meaningful in Feb 2025, at 388×.

On the days it had one over the last 7 years, its median was 49.7×, from 10.2× in Feb 2023 to 451× in Nov 2024.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	388×	388×	410×
2024	410×	54.9×	451×
2023	55.5×	10.2×	55.5×
2022	10.5×	10.2×	23.6×
2021	n/m a value too high to mean anything
2020	289×	57.3×	291×
2019	62.9×	39.1×	62.9×

Against its peers

Companies in Drug Manufacturers - General nearest Elanco Animal Health's size, closest first, today.

Company	EV/EBIT
ELANElanco Animal Health	n/m
BMRNBiomarin Pharmaceutical	25.8×
CORTCorcept Therapeutics	n/m
JAZZJazz Pharmaceuticals	15.9×
PTGXProtagonist Therapeutics	140×
TGTXTG Therapeutics	62.2×
ALKSAlkermes plc.	69.6×
AMRXAmneal Pharmaceuticals	18.3×
LGNDLigand Pharmaceuticals	57.7×
KNSAKiniksa Pharmaceuticals International	54.6×
INDVIndivior Pharmaceuticals	7.8×
Peer median	54.6×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Elanco Animal Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.